Clinical Trials Browser

INDUSTRY × glembatumumab vedotin × Breast × Clear all

NCT01997333 2019-03-08

METRIC

Phase 2 Completed

327 enrolled 17 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03067935 2018-05-21

Individual Patient Expanded Access-Glembatumumab Vedotin

No longer available

Metastatic gpNMB Expressing Triple Negative Breast Cancer

NCT01156753 2017-07-02

EMERGE

Phase 2 Completed

Breast Neoplasms